| |||||||
Following the establishment of the MaReCuM curriculum, the Faculty of Clinical Medicine Mannheim of the University of Heidelberg was reformed into the full Medical Faculty Mannheim of the University of Heidelberg in October 2006. As part of this restructuring, the research Centre for Biomedicine and Medical Technology Mannheim (CBTM) has recently been inaugurated. Being part of the first medical faculty in Germany to abandon the classical structuring of institutes into the preclinical disciplines of anatomy, physiology and biochemistry, the CBTM is organized into the interdisciplinary research divisions of Vascular Biology, Molecular Oncology, Neurobiology and Medical Technology that correspond to the priority research areas of the faculty. The research groups of the CBTM have committed themselves to pursuing cutting-edge biomedical research at the highest international level. While primarily following a basic science-oriented mission, the CBTM is embedded into the faculty's overall research priorities, and thus is fully integrated with ongoing translational and clinical research activities.
The first laboratories of the CBTM started to operate in January 2008. The centre is presently going through an intense phase of recruitment and growth to achieve an eventual size of 200 to 250 employees. This workforce will be organized into 20 research groups (MaReCuM professors, endowed chairs, young investigator groups) whose work is supported by a comprehensive network of core facilities. Collectively, the centre will have 2.000 m2 of modern state-of-the-art research laboratories.
Further information about research at the CBTM can be found on the web pages of each Research Division and their component laboratories:
